Jay Lessler concentrates his practice in domestic and foreign patent
procurement, client counseling and patent litigation, primarily in the
chemical, pharmaceutical, and computer software arts.
Working closely with inventors and in-house counsel, Mr. Lessler devises
effective strategies to build and protect intellectual property assets, from
initial drafting of patent applications to post-grant proceedings.
His experience includes:
- reissue
- reexamination and patent term extension proceedings
- domestic and foreign patent portfolios
- conducting due diligence investigations and validity and freedom-to-operate studies
- counseling clients in connection with the Hatch-Waxman Act and the Biologics Price Competition and Innovation Act preparation of Paragraph IV Notice letters and Offers for Confidential Access pursuant to the Hatch-Waxman Act
Mr. Lessler also has significant ANDA and biotech litigation experience.
His recent representations include:
- Ascio Pharmaceuticals, Inc. v. Three Rivers Pharmaceuticals, LLC (D. Ga., Civ. No. 1:10-cv-1583)
- Schering Corp., et al. v. Glenmark Pharmaceuticals, Inc. USA, et al. (D.N.J., Civ. No. 2:07-cv-01334)
Mr. Lessler has been the co-chair of Practising Law Institute’s (PLI’s) annual Advanced Patent Prosecution Workshop since 2006. He was also a speaker at PLI’s Patent Boot Camp Workshop from 2002 to 2006.